Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
SP
Specialty Pharma ApS
aktivCVR 38476599AnpartsselskabParcelvej 11, 2840 HolteVirksomhedsrådgivning og anden ledelsesrådgivning
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 06 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
Not disclosed—
Not disclosed
Operating profit
DKK -70.7k
Latest period
Source details
Source: dk-regnskabsdata-live-38476599-1793935118680
Document: dk-regnskabsdata-38476599-AZzR08RHJz_uA5CLW0WR-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c0
Unit: u0
Net result
DKK -58.6k
Latest period
Source details
Source: dk-regnskabsdata-live-38476599-1793935118680
Document: dk-regnskabsdata-38476599-AZzR08RHJz_uA5CLW0WR-1
XBRL: fsa:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c0
Unit: u0
Equity
DKK -17.8k
Equity ratio: -20.8%
Source details
Source: dk-regnskabsdata-live-38476599-1793935118680
Document: dk-regnskabsdata-38476599-AZzR08RHJz_uA5CLW0WR-1
XBRL: fsa:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c4
Unit: u0
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | — | DKK 41 |
| 2023 | — | DKK 81 |
| 2024 | — | -DKK 54 |
| 2025 | — | DKK -58.6k |